Table 2 Quantification/interpretation of hemodynamic monitoring and changes in hemodynamic management
Quantification/interpretation of all hemodynamic monitoring | Changes in hemodynamic management based on information acquired by hemodynamic monitoring? |
|---|---|
• Systolic LV function: normal – moderately decreased – severely decreased? • RV dysfunction: present –absent? • Hypovolemia: present – absent? • Clinically significant pericardial effusion: present – absent? • Was the information acquired by hemodynamic monitoring useful to guide hemodynamic management? Yes – no? • Is there need for further monitoring? Yes – no? | • No changes • Additional fluids given • Start/increase of inotropes (epinephrine, dobutamine, milrinone, aminophylline) • Stop/decrease inotropes (epinephrine, dobutamine, milrinone, aminophylline) • Start/increase of vasopressors (norepinephrine, vasopressin) • Stop/decrease of vasopressors (norepinephrine, vasopressin) • Drainage of pericardial effusion • Other (to be specified) |